Roth Capital Brokers Increase Earnings Estimates for Joint

The Joint Corp. (NASDAQ:JYNT) – Research analysts at Roth Capital increased their Q1 2026 earnings estimates for Joint in a research note issued on Thursday, August 7th. Roth Capital analyst G. Kelly now forecasts that the company will earn $0.17 per share for the quarter, up from their previous forecast of $0.14. The consensus estimate for Joint’s current full-year earnings is $0.11 per share. Roth Capital also issued estimates for Joint’s Q2 2026 earnings at $0.19 EPS, Q3 2026 earnings at $0.18 EPS and Q4 2026 earnings at $0.26 EPS.

Other equities analysts also recently issued research reports about the stock. Lake Street Capital cut their price target on shares of Joint from $20.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, May 9th. B. Riley cut their price target on shares of Joint from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday.

Joint Stock Performance

Shares of NASDAQ JYNT opened at $10.80 on Monday. Joint has a 1 year low of $9.58 and a 1 year high of $13.47. The firm’s 50 day moving average price is $11.48 and its 200 day moving average price is $11.10. The firm has a market cap of $165.24 million, a P/E ratio of -32.73 and a beta of 1.53.

Joint (NASDAQ:JYNT) last announced its earnings results on Thursday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Joint had a negative net margin of 7.02% and a positive return on equity of 0.67%. The firm had revenue of $13.27 million for the quarter, compared to analyst estimates of $13.32 million.

Hedge Funds Weigh In On Joint

Several hedge funds and other institutional investors have recently made changes to their positions in JYNT. Geode Capital Management LLC lifted its holdings in shares of Joint by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 293,133 shares of the company’s stock valued at $3,116,000 after acquiring an additional 1,552 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Joint by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 5,088 shares of the company’s stock valued at $54,000 after acquiring an additional 1,735 shares in the last quarter. Barclays PLC lifted its holdings in shares of Joint by 6.9% during the 4th quarter. Barclays PLC now owns 27,380 shares of the company’s stock valued at $291,000 after acquiring an additional 1,771 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Joint by 4.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 216,254 shares of the company’s stock valued at $2,299,000 after acquiring an additional 10,074 shares in the last quarter. Finally, Topline Capital Management LLC acquired a new position in shares of Joint during the 4th quarter valued at $3,458,000. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint declared that its board has authorized a stock buyback plan on Thursday, June 5th that allows the company to buyback $5.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 2.7% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.